KR20100037633A - Ｅｇｆｒ 저해제 치료에 대한 예측 마커 - Google Patents

Ｅｇｆｒ 저해제 치료에 대한 예측 마커 Download PDF

Info

Publication number
KR20100037633A
KR20100037633A KR1020107003252A KR20107003252A KR20100037633A KR 20100037633 A KR20100037633 A KR 20100037633A KR 1020107003252 A KR1020107003252 A KR 1020107003252A KR 20107003252 A KR20107003252 A KR 20107003252A KR 20100037633 A KR20100037633 A KR 20100037633A
Authority
KR
South Korea
Prior art keywords
treatment
cancer
patients
patient
analysis
Prior art date
Application number
KR1020107003252A
Other languages
English (en)
Korean (ko)
Inventor
뽈 델마
바르바라 클루그함머
베레나 루츠
파트리샤 맥러플린
Original Assignee
에프. 호프만-라 로슈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 호프만-라 로슈 아게 filed Critical 에프. 호프만-라 로슈 아게
Publication of KR20100037633A publication Critical patent/KR20100037633A/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
KR1020107003252A 2007-08-14 2008-08-07 Ｅｇｆｒ 저해제 치료에 대한 예측 마커 KR20100037633A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07114305.1 2007-08-14
EP07114305 2007-08-14

Publications (1)

Publication Number Publication Date
KR20100037633A true KR20100037633A (ko) 2010-04-09

Family

ID=39789783

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107003252A KR20100037633A (ko) 2007-08-14 2008-08-07 Ｅｇｆｒ 저해제 치료에 대한 예측 마커

Country Status (9)

Country Link
EP (1) EP2176429A1 (de)
JP (1) JP2010535520A (de)
KR (1) KR20100037633A (de)
CN (1) CN101802221A (de)
AU (1) AU2008286412A1 (de)
BR (1) BRPI0815372A2 (de)
CA (1) CA2695318A1 (de)
MX (1) MX2010001572A (de)
WO (1) WO2009021679A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646249A (en) * 1994-02-28 1997-07-08 The United States Of America As Represented By The Department Of Health And Human Services Isolation and characterization of a novel chaperone protein
WO2004111273A2 (en) * 2003-05-30 2004-12-23 Genomic Health, Inc. Gene expression markers for response to egfr inhibitor drugs
EP2348110B1 (de) * 2003-05-30 2013-03-27 OncoTherapy Science, Inc. Prozess zum screening einer medikamentenansprache in krebspatienten

Also Published As

Publication number Publication date
WO2009021679A1 (en) 2009-02-19
BRPI0815372A2 (pt) 2019-09-24
MX2010001572A (es) 2010-03-15
CA2695318A1 (en) 2009-02-19
JP2010535520A (ja) 2010-11-25
CN101802221A (zh) 2010-08-11
EP2176429A1 (de) 2010-04-21
AU2008286412A1 (en) 2009-02-19

Similar Documents

Publication Publication Date Title
US20110218212A1 (en) Predictive markers for egfr inhibitors treatment
KR101169244B1 (ko) Ｅｇｆｒ 억제제 치료에 대한 예측 마커
EP2179056B1 (de) Egfr-inhibitor-behandlungsmarker
KR101169246B1 (ko) Ｅｇｆｒ 저해제 치료에 대한 예측 마커
KR101169245B1 (ko) Ｅｇｆｒ 저해제 치료에 대한 예측 마커
KR20100044851A (ko) Ｅｇｆｒ 억제제를 이용한 치료에 대한 예측 마커
KR20100037633A (ko) Ｅｇｆｒ 저해제 치료에 대한 예측 마커
KR20100037638A (ko) Ｅｇｆｒ 억제제를 이용한 치료에 대한 예측 마커
US20130217712A1 (en) Predictive marker for egfr inhibitor treatment
AU2008286410A1 (en) Predictive marker for EGFR inhibitor treatment

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application